Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Nanjing Vazyme Biotech Co., Ltd

Market Cap 725.85Cr 107.13Cr 93Cr 86Cr 80Cr 150.02Cr 10TCr 153.15Cr 1.02TCr 395.76Cr 4.94TCr 402.15Cr 393.48Cr 17TCr P/E Ratio 2026 *
59.8x
P/E Ratio 2027 * 53.7x
Enterprise Value 725.85Cr 107.13Cr 93Cr 86Cr 80Cr 150.02Cr 10TCr 153.15Cr 1.02TCr 395.76Cr 4.94TCr 402.15Cr 393.48Cr 17TCr EV / Sales 2026 *
4.53x
EV / Sales 2027 * 3.63x
Free-Float
24.14%
Yield 2026 *
0.44%
Yield 2027 * 0.55%
1 day+3.16%
1 week+1.74%
Current month-4.59%
1 month-10.40%
3 months-11.27%
6 months-13.54%
Current year-8.83%
1 week 12.89
Extreme 12.89
14.07
1 month 12.89
Extreme 12.89
16.38
Current year 12.89
Extreme 12.89
18.42
1 year 12.89
Extreme 12.89
20.59
3 years 12.89
Extreme 12.89
31.92
5 years 12.89
Extreme 12.89
100.38
10 years 12.89
Extreme 12.89
100.38
Manager TitleAgeSince
Chief Executive Officer 47 01/03/2012
Director of Finance/CFO 50 01/09/2016
Human Resources Officer 37 -
Director TitleAgeSince
Chairman 47 01/03/2020
Director/Board Member 59 01/03/2020
Director/Board Member 43 01/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
+3.16%+1.74%-20.23%-49.58% 103.85Cr
+2.15%+3.31%+43.77%+161.06% 1,01300Cr
+0.56%+5.17%+54.56%+50.08% 57TCr
+0.36%+0.49%+18.04%+64.12% 40TCr
-0.37%+4.97%+21.24%+15.95% 32TCr
+0.85%+0.18%+24.50%+14.78% 28TCr
+2.10%+4.92%+25.30%+33.80% 27TCr
+3.83%+1.33%+20.01%+61.11% 18TCr
-0.19%-0.46%-45.32%-48.35% 19TCr
+3.55%-2.52%+15.21%+61.73% 15TCr
Average +1.59%+2.86%+15.71%+36.47% 33.9TCr
Weighted average by Cap. +1.33%+3.99%+29.68%+72.87%

Financials

2026 *2027 *
Net sales 160.25Cr 24Cr 21Cr 19Cr 18Cr 33Cr 2.26TCr 34Cr 225.68Cr 87Cr 1.09TCr 89Cr 87Cr 3.8TCr 200.03Cr 30Cr 26Cr 24Cr 22Cr 41Cr 2.83TCr 42Cr 281.71Cr 109.07Cr 1.36TCr 110.83Cr 108.44Cr 4.74TCr
Net income 12Cr 1.8Cr 1.56Cr 1.44Cr 1.35Cr 2.52Cr 172.4Cr 2.57Cr 17Cr 6.65Cr 83Cr 6.76Cr 6.61Cr 288.96Cr 13Cr 1.99Cr 1.72Cr 1.59Cr 1.49Cr 2.78Cr 190.3Cr 2.84Cr 19Cr 7.34Cr 92Cr 7.46Cr 7.3Cr 318.96Cr
Net Debt - -
Logo Nanjing Vazyme Biotech Co., Ltd
Nanjing Vazyme Biotech Co Ltd is China-based company principally engaged in life sciences, in vitro diagnostics, and biopharmaceuticals. Its products and services cover basic research reagents, high-throughput sequencing reagents, diagnostic raw materials, laboratory consumables and instruments, pharmaceutical R&D reagents, vaccine evaluation reagents and raw materials, etc. The company's products are mainly used in scientific research, high-throughput sequencing, molecular diagnostics, in vitro diagnostics, pharmaceutical, vaccine research and development, animal husbandry, and animal quarantine. The Company mainly conducts its business in the domestic and overseas markets.
Employees
3,002
Date Price Change Volume
11/26/11 14.04 ¥ +3.16% 33,75,784
10/26/10 13.61 ¥ +0.22% 32,63,096
09/26/09 13.58 ¥ +3.35% 43,38,319
08/26/08 13.14 ¥ -1.94% 28,56,636
05/26/05 13.40 ¥ +0.75% 25,24,508
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
14.04CNY
Average target price
20.57CNY
Spread / Average Target
+46.48%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 688105 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!